AI-assisted assessment of the IFSO consensus on obesity management medications in the context of metabolic bariatric surgery.

ABSTRACT: Artificial intelligence (AI) and large language models (LLMs), when combined with human expertise in collaborative intelligence (CI), can enhance medical decision-making, reduce bias in guideline development, and support precision care. New obesity management medications (OMMs) such as GLP-1 receptor agonists and dual incretin mimetics complement metabolic bariatric surgery but currently lack clear integration strategies. To address this gap, IFSO released consensus guidelines in 2024. This study evaluates their robustness by comparing expert recommendations with LLM outputs, highlighting the role of AI in assessment and strengthening clinical consensus. Thirty-one IFSO consensus statements were tested across eleven advanced LLMs on June 1, 2025. Models received standardized prompts that r

SUBMITTER: Kermansaravi M 

PROVIDER: S-EPMC12716726 | biostudies-literature | 2025 Dec

REPOSITORIES: biostudies-literature